Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
LY4101174 and LY4052031 are two next-generation Nectin-4-targeting ADCs that have demonstrated robust antitumor activity across a range of Nectin-4 expression levels and in a Nectin-4-MMAE ADC-resistant tumor model in the preclinical setting 185,186
This data-driven framework brings greater scientific rigor and systematicity to target discovery in the context of Chinese medicine
Cells were trypsinized for 5 min at 37 C, diluted in DMEM, and centrifuged at 400 g for 10 min
List of all such bioinformatics and AI based tools and resources specific to breast cancer research is provided in Table 4
US$ 29.21
US$ 26.16
US$ 20.48
